反应详情

(1H-Benzoimidazol-2-yl)-{3-[3-(4-hydroxy-piperidin-1-yl)-pyrazin-2-yl]-azetidin-1-yl}-methanone (0.16 g, 0.42 mmol) was dissolved in anhydrous CH2Cl2 (20 mL), treated with Dess-Martin Periodinane (DMP) (195 mg, 0.46 mmol, 1.1 equiv) and stirred at RT until complete conversion controlled by TLC (Petro ether:EtOAc=1:1). The organic layer was washed with an aqueous solution of NaHCO3/Na2S2O3 (3×10 mL)), dried over Na2SO4, filtered and evaporated. The resulting residue was purified by flash chromatography (20% to 40% EtOAc in petroleum ether) to give 1-{3-[1-(1H-benzoimidazole-2-carbonyl)-azetidin-3-yl]-pyrazin-2-yl}-piperidin-4-one (0.134 g, 0.36 mmol, 85% yield) as a white solid.

1. washThe organic layer was washed with an aqueous solution of NaHCO3/Na2S2O3 (3×10 mL)),
2. dry with materialdried over Na2SO4
3. filtrationfiltered
4. customevaporated
5. customThe resulting residue was purified by flash chromatography (20% to 40% EtOAc in petroleum ether)